Budget Impact Analysis of the GeneXpert System for Preventing Acute Respiratory Infections in Nursing Homes

Purpose Acute respiratory infections (ARIs) cause substantial morbidity, mortality, and healthcare use in nursing homes, where delayed diagnosis facilitates transmission. This study assessed the clinical and budget impact of introducing point-of-care multiplex PCR testing with the GeneXpert® system and Xpert® Xpress CoV-2/Flu/RSV plus in French nursing homes. Methods A one-year budget impact model compared the current standard of care, based on rapid antigen tests and delayed PCR testing, with a “Test and Isolation” strategy using GeneXpert® at symptom onset. The analysis adopted the French mandatory health insurance perspective and included all 587,566 permanent residents of 7,519 nursing homes. Inputs were derived from published literature, national surveillance networks, and French health insurance data. Outcomes included numbers of tests, ARI clusters, hospitalizations, screening costs, and total budget impact. Key parameters were varied by ± 10% in deterministic sensitivity analyses. Results GeneXpert® was projected to reduce annual testing by 67%, from 119,693 to 39,898 tests, and ARI clusters by 35%, from 6,439 to 4,165. ARI cases decreased from 141,669 to 91,634, while hospitalizations fell by 35%, from 9,208 to 5,956. Despite a higher unit test cost (€45 vs €15), total screening costs were identical (€1,795,400) because fewer tests were required. Reduced hospitalizations generated annual savings of €15,202,734. Sensitivity analyses estimated savings ranging from €12.0 million to €19.2 million. Conclusion Point-of-care multiplex PCR testing with GeneXpert® may enable earlier detection and isolation of ARIs in nursing homes, reducing transmission and hospitalizations while generating substantial savings for the French health insurance system.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11567052/v1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Budget Impact Analysis of the GeneXpert System for Preventing Acute Respiratory Infections in Nursing Homes

Olivier Hanon, Thomas Célarier, Slim Fourati, Quentin Berkovitch et al.
4 links
Research Square
Health Systems, Economic Evaluations, Quality of Life
preprint

Budget Impact Analysis of the GeneXpert System for Preventing Acute Respiratory Infections in Nursing Homes

Olivier Hanon, Thomas Célarier, Slim Fourati, Quentin Berkovitch, FLORENCE DECOTTIGNIES, HENRI LESAGE
preprint en

Abstract

Purpose Acute respiratory infections (ARIs) cause substantial morbidity, mortality, and healthcare use in nursing homes, where delayed diagnosis facilitates transmission. This study assessed the clinical and budget impact of introducing point-of-care multiplex PCR testing with the GeneXpert® system and Xpert® Xpress CoV-2/Flu/RSV plus in French nursing homes. Methods A one-year budget impact model compared the current standard of care, based on rapid antigen tests and delayed PCR testing, with a “Test and Isolation” strategy using GeneXpert® at symptom onset. The analysis adopted the French mandatory health insurance perspective and included all 587,566 permanent residents of 7,519 nursing homes. Inputs were derived from published literature, national surveillance networks, and French health insurance data. Outcomes included numbers of tests, ARI clusters, hospitalizations, screening costs, and total budget impact. Key parameters were varied by ± 10% in deterministic sensitivity analyses. Results GeneXpert® was projected to reduce annual testing by 67%, from 119,693 to 39,898 tests, and ARI clusters by 35%, from 6,439 to 4,165. ARI cases decreased from 141,669 to 91,634, while hospitalizations fell by 35%, from 9,208 to 5,956. Despite a higher unit test cost (€45 vs €15), total screening costs were identical (€1,795,400) because fewer tests were required. Reduced hospitalizations generated annual savings of €15,202,734. Sensitivity analyses estimated savings ranging from €12.0 million to €19.2 million. Conclusion Point-of-care multiplex PCR testing with GeneXpert® may enable earlier detection and isolation of ARIs in nursing homes, reducing transmission and hospitalizations while generating substantial savings for the French health insurance system.

Research Square
Centre Hospitalier Universitaire Henri-Mondor (FR), Hôpital Broca (FR), Hôpitaux Universitaires Henri-Mondor (FR), Centre Hospitalier Universitaire de Saint-Étienne (FR)
Good health and well-being
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon